Runben Biotechnology Co., Ltd. (SHA:603193)
China · Delayed Price · Currency is CNY 20.25
+0.25 (1.25%)
Sep 30, 2026, 3:00 PM CST
Runben Biotechnology Market Cap
Runben Biotechnology has a market cap or net worth of 8.19 billion as of October 6, 2026. Its market cap has decreased by -29.02% in one year.
Market Cap
8.19B
Enterprise Value
6.68B
Revenue
1.70B
Ranking
n/a
PE Ratio
23.03
Stock Price
20.25
ChartMarket Cap Chart
Since October 17, 2023, Runben Biotechnology's market cap has decreased from 8.93B to 8.19B, a decrease of -8.29%. That is a compound annual growth rate of -2.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 8.19B | -16.43% |
| Dec 31, 2025 | 9.80B | 3.77% |
| Dec 31, 2024 | 9.45B | 28.44% |
| Dec 29, 2023 | 7.36B | -17.66% |
| Oct 17, 2023 | 8.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding